OGT expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.6247892748188E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.52374999999871E-05 |
Normal-vs-Stage2 |
8.36990000000482E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.969000E-04 |
Stage1-vs-Stage2 |
9.986200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.731000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.652200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.96090033099949E-10 |
Normal-vs-AfricanAmerican |
1.671160E-01 |
Normal-vs-Asian |
3.483600E-02 |
Caucasian-vs-AfricanAmerican |
2.879400E-01 |
Caucasian-vs-Asian |
5.511200E-01 |
AfricanAmerican-vs-Asian |
5.755400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.61369999995831E-06 |
Normal-vs-Female |
1.57370000031243E-07 |
Male-vs-Female |
5.682000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.177970E-03 |
Normal-vs-Extreme_Weight |
2.02350000000351E-06 |
Normal-vs-Obese |
3.796500E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.616400E-01 |
Normal_Weight-vs-Obese |
6.828800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.955200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.683600E-01 |
Normal-vs-Age(41-60Yrs) |
2.155300E-04 |
Normal-vs-Age(61-80Yrs) |
9.64470000530682E-08 |
Normal-vs-Age(81-100Yrs) |
2.630000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.536200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.252800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.193600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.346400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.861000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.753000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.104800E-01 |
Normal-vs-Grade 3 |
9.429600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.958600E-01 |
Grade 2-vs-Grade 4 |
7.104800E-01 |
Grade 3-vs-Grade 4 |
9.429600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.02389999812047E-08 |
Normal-vs-N1 |
6.982000E-04 |
N0-vs-N1 |
4.994000E-01 |
|
|